# Relay Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/relay-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 31 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:43:35.944226+00:00 | | Last reviewed | 2026-10-19T14:43:35.944226+00:00 | ## Identity - Legal name: Relay Therapeutics, Inc. - Display name: Relay Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T19:26:51.170655+00:00 | | Completeness | 0.409 | | Record Quality | 0.827 | | Directors | 13 | | Committees | 4 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Claire Mazumdar: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. Committees: AUDIT COMMITTEE (chair); compensation committee (chair); Nominating and Corporate Governance Committee (chair). claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:6 - Douglas S. Ingram: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. Committees: compensation committee (chair). claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:8 - Habib Joseph Dable: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:9 - Linda A. Hill: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:10 - Lonnel Coats: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. Committees: AUDIT COMMITTEE (member); compensation committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:12 - Mark Murcko: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:13 - Sekar Kathiresan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:16 - Alexis Borisy: Chairperson and Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:5 - Claire Mazumdar, Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:7 - Linda A. Hill, Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:11 - Mark Murcko, Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:14 - Sanjiv K. Patel, M.D.: Director, President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Chief Executive Officer (member). claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:15 - Sekar Kathiresan, M.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:17 ## Committees - AUDIT COMMITTEE (audit). Chair: Claire Mazumdar. Members: Claire Mazumdar (chair, current); Lonnel Coats (member, current). committee_id=alpha:committee:relay-therapeutics-inc:audit-committee - compensation committee (compensation). Chair: Douglas S. Ingram. Members: Claire Mazumdar (chair, current); Douglas S. Ingram (chair, current); Lonnel Coats (member, current). committee_id=alpha:committee:relay-therapeutics-inc:compensation-committee - Nominating and Corporate Governance Committee (nominating_governance). Chair: Claire Mazumdar. Members: Claire Mazumdar (chair, current); Lonnel Coats (member, current). committee_id=alpha:committee:relay-therapeutics-inc:nominating-and-corporate-governance-committee - President and Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: Sanjiv K. Patel, M.D. (member, unknown). committee_id=alpha:committee:relay-therapeutics-inc:president-and-chief-executive-officer ## Executive leadership - Donald Bergstrom, M.D., Ph.D.: President, Research & Development [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:18 - Peter Rahmer: Chief Corporate Development Officer. Status: unknown. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:19 - Sanjiv K. Patel, M.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:20 - Thomas Catinazzo: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:21 ## Governance events - DIRECTOR_APPOINTED: Claire Mazumdar seat on Relay Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:1b6m2c911vaovj - DIRECTOR_APPOINTED: Habib Joseph Dable seat on Relay Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:e4oq821pjbz3c - DIRECTOR_APPOINTED: Lonnel Coats seat on Relay Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:zxq8fwtu75l6 - DIRECTOR_APPOINTED: Sekar Kathiresan seat on Relay Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:x224t1d3709h - DIRECTOR_APPOINTED: Douglas S. Ingram seat on Relay Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:10r7t6899so0u - DIRECTOR_APPOINTED: Linda A. Hill seat on Relay Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:dsmsvwpgeqjy - DIRECTOR_APPOINTED: Mark Murcko seat on Relay Therapeutics, Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-19T14:43:35.944226+00:00. event_id=alpha:event:transition:1vv0l871mbwb9z ## Scoped resources - `alpha://company/relay-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record - `alpha://company/relay-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=identity - `alpha://company/relay-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/relay-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=board - `alpha://company/relay-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=committees - `alpha://company/relay-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=leadership - `alpha://company/relay-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=ownership - `alpha://company/relay-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=financials - `alpha://company/relay-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/relay-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=compensation - `alpha://company/relay-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=governance - `alpha://company/relay-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/relay-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=audit - `alpha://company/relay-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=legal - `alpha://company/relay-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=risk - `alpha://company/relay-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=cyber - `alpha://company/relay-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/relay-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=agents - `alpha://company/relay-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/relay-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=events - `alpha://company/relay-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=relationships - `alpha://company/relay-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=assessments - `alpha://company/relay-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:23: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:claire-mazumdar-rlay","name":"Claire Mazumdar"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:24: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lonnel-coats-rlay","name":"Lonnel Coats"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:26: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:claire-mazumdar-rlay","name":"Claire Mazumdar"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:27: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:douglas-s-ingram-rlay","name":"Douglas S. Ingram"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:28: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lonnel-coats-rlay","name":"Lonnel Coats"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:claire-mazumdar-rlay","name":"Claire Mazumdar"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lonnel-coats-rlay","name":"Lonnel Coats"},"source_id":"governance_people_committees"}` ## Leadership - Alexis Borisy: Chairperson and Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Claire Mazumdar: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Claire Mazumdar, Ph.D.: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Douglas S. Ingram: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Habib Joseph Dable: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Linda A. Hill: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Linda A. Hill, Ph.D.: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Lonnel Coats: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:12. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Mark Murcko: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:13. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Mark Murcko, Ph.D.: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Sanjiv K. Patel, M.D.: Director, President and Chief Executive Officer. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Sekar Kathiresan: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:16. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9. - Sekar Kathiresan, M.D.: Director. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Donald Bergstrom, M.D., Ph.D.: President, Research & Development. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Peter Rahmer: Chief Corporate Development Officer. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Sanjiv K. Patel, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. - Thomas Catinazzo: Chief Financial Officer. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - AUDIT COMMITTEE: Chair Claire Mazumdar; Members Claire Mazumdar (Chair); Lonnel Coats. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - compensation committee: Chair Claire Mazumdar; Douglas S. Ingram; Members Claire Mazumdar (Chair); Douglas S. Ingram (Chair); Lonnel Coats. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Nominating and Corporate Governance Committee: Chair Claire Mazumdar; Members Claire Mazumdar (Chair); Lonnel Coats. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_record:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Relay Therapeutics, Inc.. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:961fe4002498fd0a8a952309e95ac080f7fa682c9bc1abd53af9694d375201eb. ## Entity Status - Public listing published. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:961fe4002498fd0a8a952309e95ac080f7fa682c9bc1abd53af9694d375201eb. ## Published Fact - US. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:961fe4002498fd0a8a952309e95ac080f7fa682c9bc1abd53af9694d375201eb. ## Committee Appointment - Claire Mazumdar: chair, AUDIT COMMITTEE. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Lonnel Coats: member, AUDIT COMMITTEE. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Claire Mazumdar: chair, compensation committee. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Douglas S. Ingram: chair, compensation committee. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Lonnel Coats: member, compensation committee. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Claire Mazumdar: chair, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. - Lonnel Coats: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da. ## Security Listing - RLAY (NASDAQ). Claim: alpha:claim:company:6252cfe3-9b38-4c0d-9631-bd0688b7128c:security_listing:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:961fe4002498fd0a8a952309e95ac080f7fa682c9bc1abd53af9694d375201eb. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:961fe4002498fd0a8a952309e95ac080f7fa682c9bc1abd53af9694d375201eb: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/relay-therapeutics-inc). - alpha:projection-evidence:document:da307fd36e385b3a52950a5be25d25afe4bccddb884137c43132464543c027df: [SEC DEF 14A 0001193125-26-186929](https://www.sec.gov/Archives/edgar/data/1812364/000119312526186929/rlay-20260424.htm). - alpha:projection-evidence:document:0fbb55b6b3363ce923864c4bde2d56925eeec9b5cd2ab4f2cbb56e3fc522fde9: [DEF 14A rlay-20260424.htm](https://www.sec.gov/Archives/edgar/data/1812364/000119312526186929/rlay-20260424.htm). - alpha:projection-evidence:af1a91cc5332bbdd8a1609b2bb7532d7a889f23a6ff6e68b84523026de4b97da: [AUDIT COMMITTEE](https://www.sec.gov/Archives/edgar/data/1812364/000119312526186929/rlay-20260424.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/relay-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/relay-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/relay-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/relay-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T19:26:50.943227+00:00; recorded 2026-10-19T19:26:50.943227+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.